Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and SepsisChristopher Geven, Peter Pickkers, Andreas Bergmann et al.|Shock|2018Cited by 48
Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primatesChristopher Geven, Peter Pickkers, Matthijs Kox et al.|Toxicology and Applied Pharmacology|2019Cited by 4